




The above list only scratches the surface of what human cloning technology can do for mankind. The suffering that can be relieved is staggering. This new technology heralds a new era of unparalleled advancement in medicine if people will release their fears and let the benefits begin. Why should another child die from leukemia when if the technology is allowed we should be able to cure it in a few years time?
From various e-mail sent to the Human Cloning Foundation, it is clear that many people would support human cloning in the following situations:
1) A couple has one child then they become infertile and cannot have more children. Cloning would enable such a couple to have a second child, perhaps a younger twin of the child they already have.
2) A child is lost soon after birth to a tragic accident. Many parents have written the HCF after losing a baby in a fire, car accident, or other unavoidable disaster. These grief stricken parents often say that they would like to have their perfect baby back. Human cloning would allow such parents to have a twin of their lost baby, but it would be like other twins, a unique individual and not a carbon copy of the child that was lost under heartbreaking circumstances.
3) A woman who through some medical emergency ended up having a hysterectomy before being married or having children. Such women have been stripped of their ability to have children. These women need a surrogate mother to have a child of their own DNA, which can be done either by human cloning or by in vitro fertilization.
4) A boy graduates from high school at age 18. He goes to a pool party to celebrate. He confuses the deep end and shallow end and dives head first into the pool, breaking his neck and becoming a quadriplegic. At age 19 he has his first urinary tract infection because of an indwelling urinary catheter and continues to suffer from them the rest of his life. At age 20 he comes down with herpes zoster of the trigeminal nerve. He suffers chronic unbearable pain. At age 21 he inherits a 10 million dollar trust fund. He never marries or has children. At age 40 after hearing about Dolly being a clone, he changes his will and has his DNA stored for future human cloning. His future mother will be awarded one million dollars to have him and raise him. His DNA clone will inherit a trust fund. He leaves five million to spinal cord research. He dies feeling that although he was robbed of normal life, his twin/clone will lead a better life.
5) Two parents have a baby boy. Unfortunately the baby has muscular dystrophy. They have another child and it's another boy with muscular dystrophy. They decide not to have any more children. Each boy has over 20 operations as doctors attempt to keep them healthy and mobile. Both boys die as teenagers. The childless parents donate their estate to curing muscular dystrophy and to having their boys cloned when medical science advances enough so that their DNA can live again, but free of muscular dystrophy.
Reference this page as: Human Cloning Foundation. "The Benefits of Human Cloning." Internet http://www.humancloning.org/benefits.htm, 1998.
How Dolly was cloned
Animal cloning from an adult cell is obviously much more complex and difficult than growing a plant from a cutting. So when scientists working at the Roslin Institute in Scotland produced Dolly, the only lamb born from 277 attempts, it was a major news story around the world.
To produce Dolly, the scientists used the nucleus of an udder cell from a six-year-old Finn Dorset white sheep. The nucleus contains nearly all the cell's genes. They had to find a way to 'reprogram' the udder cells - to keep them alive but stop them growing – which they achieved by altering the growth medium (the ‘soup’ in which the cells were kept alive). Then they injected the cell into an unfertilised egg cell which had had its nucleus removed, and made the cells fuse by using electrical pulses. The unfertilised egg cell came from a Scottish Blackface ewe. When the research team had managed to fuse the nucleus from the adult white sheep cell with the egg cell from the black-faced sheep, they needed to make sure that the resulting cell would develop into an embryo. They cultured it for six or seven days to see if it divided and developed normally, before implanting it into a surrogate mother, another Scottish Blackface ewe. Dolly had a white face.
From 277 cell fusions, 29 early embryos developed and were implanted into 13 surrogate mothers. But only one pregnancy went to full term, and the 6.6kg Finn Dorset lamb 6LLS (alias Dolly) was born after 148 days.
What happened to Dolly?
Dolly, lived a pampered existence at the Roslin Institute. She mated and produced normal offspring in the normal way, showing that such cloned animals can reproduce. Born on 5 July 1996, she was euthanased on 14 February 2003, aged six and a half. Sheep can live to age 11 or 12, but Dolly suffered from arthritis in a hind leg joint and from sheep pulmonary adenomatosis, a virus-induced lung tumour to which sheep raised indoors are prone. On 2 February 2003, Australia's first cloned sheep died unexpectedly at the age of two years and 10 months. The cause of death was unknown and the carcass was quickly cremated as it was decomposing.
Dolly’s chromosomes were a little shorter than those of other sheep, but in most other ways she was the same as any other sheep of her chronological age. However, her early ageing may reflect that she was raised from the nucleus of a 6-year old sheep. Study of her cells also revealed that the very small amount of DNA outside the nucleus, in the mitochondria of the cells, is all inherited from the donor egg cell, not from the donor nucleus like the rest of her DNA. So she is not a completely identical copy. This finding could be important for sex-linked diseases such as haemophilia, and certain neuromuscular, brain and kidney conditions that are passed on through the mother's side of the family only.
Why clone sheep?
Dolly the sheep, was produced at the Roslin Institute as part of research into producing medicines in the milk of farm animals. Researchers have managed to transfer human genes that produce useful proteins into sheep and cows, so that they can produce, for instance, the blood clotting agent factor IX to treat haemophilia or alpha-1-antitrypsin to treat cystic fibrosis and other lung conditions.
The development of cloning technology has led to new ways to produce medicines and is improving our understanding of development and genetics.